Form 8-K - Current report:
SEC Accession No. 0001213900-25-033837
Filing Date
2025-04-21
Accepted
2025-04-21 17:15:08
Documents
14
Period of Report
2025-04-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239052-8k_klotho.htm   iXBRL 8-K 29045
  Complete submission text file 0001213900-25-033837.txt   247326

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE klto-20250415.xsd EX-101.SCH 3496
3 XBRL DEFINITION FILE klto-20250415_def.xml EX-101.DEF 26515
4 XBRL LABEL FILE klto-20250415_lab.xml EX-101.LAB 36423
5 XBRL PRESENTATION FILE klto-20250415_pre.xml EX-101.PRE 25139
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0239052-8k_klotho_htm.xml XML 5482
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 25854356
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)